Primarily opinions of additive survival duration of the chronic myeloid leukemia patients with chronic granuliform treated by hydroxyurea
- Author:
Thanh Ha Nguyen
- Publication Type:Journal Article
- Keywords:
leukemia
- MeSH:
Leukemia, Myeloid;
Hydroxyurea;
therapeutics
- From:Journal of Vietnamese Medicine
1999;233(2):52-56
- CountryViet Nam
- Language:Vietnamese
-
Abstract:
A retrospective study was carried out in 34 chronic myeloid leukemia patients, who were followed up from the beginning stage of the disease throughout natural history of the disease. The result shows the follows: the percentage of transformation into acute myeloid leukemia was 86.7%, the percentage of transformation into acute lymphocytic leukemia was 13.3%. The median length of chronic phase was 28.9 months. The median survival was 33.6 months (52.4% patients have survived more than 52 months). Main cause of death in chronic phase was emboli due to hyperleucocytic syndrome
